S. 706 — Engrossed in Senate

113th CONGRESS 2nd Session S. 706 AN ACT To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes. 1. Short title This Act may be cited as the Transnational Drug Trafficking Act of 2013. 2. Possession, manufacture or distribution for purposes of unlawful importations Section 1009 of the Controlled Substances Import and Export Act (21 U.S.C. 959) is amended— (1) by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and (2) in subsection (a), by striking It shall and all that follows and inserting the following: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States. (b) It shall be unlawful for any person to manufacture or distribute a listed chemical— (1) intending or knowing that the listed chemical will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States. . 3. Trafficking in counterfeit goods or services Chapter 113 of title 18, United States Code, is amended— (1) in section 2318(b)(2), by striking section 2320(e) and inserting section 2320(f); and (2) in section 2320— (A) in subsection (a), by striking paragraph (4) and inserting the following: (4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug, ; (B) in subsection (b)(3), in the matter preceding subparagraph (A), by striking counterfeit drug and inserting drug that uses a counterfeit mark on or in connection with the drug; and (C) in subsection (f), by striking paragraph (6) and inserting the following: (6) the term drug means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321). . Passed the Senate December 15, 2014.Secretary